Annovis Bio, Inc. (ANVS) quarterly balance sheet — complete assets, liabilities & equity history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Total Current Assets | 16.24M | 21.08M | 17.19M | 21.45M | 26.74M | 13.93M | 14.36M | 5.05M | 7.81M | 10.21M | 10.22M | 22.82M | 25.55M | 36.02M | 32.49M | 36.53M | 43.3M | 46M | 47.65M | 49.5M |
| Cash & Short-Term Investments | 14.22M | 19.53M | 15.29M | 17.13M | 22.24M | 10.55M | 12.64M | 4M | 3.14M | 5.75M | 6.35M | 15.72M | 16.76M | 28.38M | 31.99M | 35.97M | 42.67M | 45.69M | 47.46M | 49.22M |
| Cash Only | 14.22M | 19.53M | 15.29M | 17.13M | 22.24M | 10.55M | 12.64M | 4M | 3.14M | 5.75M | 6.35M | 15.72M | 16.76M | 28.38M | 31.99M | 35.97M | 42.67M | 45.69M | 47.46M | 49.22M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 7.5K | 0 | 7.5K | 3.85M | 7.5K | 7.5K | 1.47M | 0 | 4.36M | 20.8K | 3.74M | 26.02K | 0 | 7.54M | 11.1K | 267.26K | 268.23K | 9.87K | 9.87K | 9.87K |
| Total Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 16.24M | 21.08M | 17.19M | 21.45M | 26.74M | 13.93M | 14.36M | 5.05M | 7.81M | 10.21M | 10.22M | 22.82M | 25.55M | 36.02M | 32.49M | 36.53M | 43.3M | 46M | 47.65M | 49.5M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | -39.25% | 51.39% | 19.69% | 325.14% | 242.2% | 36.42% | 40.48% | -77.88% | -69.42% | -71.66% | -68.53% | -37.53% | -40.99% | -21.69% | -31.82% | -26.21% | 625.85% | 466.57% | 406.81% | 385.2% |
| Total Current Liabilities | 12.79M | 3.64M | 3.73M | 2.81M | 2.5M | 3.88M | 5.39M | 4.06M | 4.87M | 4.28M | 3.56M | 2.07M | 5.41M | 7.7M | 2.53M | 1.3M | 1.26M | 1.51M | 1.12M | 884.08K |
| Accounts Payable | 5.28M | 2.59M | 2.11M | 974.31K | 1.37M | 2.31M | 4.1M | 3.39M | 4.11M | 1.29M | 1.93M | 1.17M | 4.15M | 3.96M | 1.85M | 901.84K | 929K | 688.07K | 289.74K | 114.83K |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 6.78M | -484 | 915.12K | 0 | 0 | 1.21M | 0 | 275.25K | 0 | 2.89M | 0 | 640.68K | 0 | 0 | 209.13K | 0 | 0 | 105.67K | 587.17K | 0 |
| Current Ratio | 1.27x | 5.80x | 4.60x | 7.65x | 10.68x | 3.59x | 2.66x | 1.24x | 1.60x | 2.39x | 2.87x | 11.00x | 4.72x | 4.68x | 12.86x | 28.11x | 34.46x | 30.54x | 42.52x | 55.99x |
| Quick Ratio | 1.27x | 5.80x | 4.60x | 7.65x | 10.68x | 3.59x | 2.66x | 1.24x | 1.60x | 2.39x | 2.87x | 11.00x | 4.72x | 4.68x | 12.86x | 28.11x | 34.46x | 30.54x | 42.52x | 55.99x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 327K | 595K | 299K | 319K | 179K | 737K | 1.91M | 2.74M | 6.3M | 13.68M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 327K | 595K | 299K | 319K | 179K | 737K | 1.91M | 2.74M | 6.3M | 13.68M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 13.12M | 4.23M | 4.03M | 3.12M | 2.68M | 4.62M | 7.3M | 6.8M | 11.17M | 17.96M | 3.56M | 2.07M | 5.41M | 7.7M | 2.53M | 1.3M | 1.26M | 1.51M | 1.12M | 884.08K |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Debt | -14.22M | -19.53M | -15.29M | -17.13M | -22.24M | -10.55M | -12.64M | -4M | -3.14M | -5.75M | -6.35M | -15.72M | -16.76M | -28.38M | -31.99M | -35.97M | -42.67M | -45.69M | -47.46M | -49.22M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | -8.37x | -5.77x | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 3.13M | 16.85M | 13.16M | 18.33M | 24.05M | 9.31M | 7.06M | -1.75M | -3.35M | -7.75M | 6.66M | 20.74M | 20.14M | 28.32M | 29.96M | 35.23M | 42.04M | 44.49M | 46.53M | 48.61M |
| Equity Growth % | -87% | 81.05% | 86.25% | 1146.93% | 817.16% | 220.09% | 6.09% | -108.44% | -116.66% | -127.37% | -77.78% | -41.12% | -52.1% | -36.34% | -35.61% | -27.54% | 862.4% | 490.04% | 410.14% | 411.8% |
| Book Value per Share | 0.11 | 0.68 | 0.67 | 0.94 | 1.97 | 0.67 | 0.54 | -0.15 | -0.32 | -0.81 | 0.74 | 2.32 | 2.46 | 3.47 | 3.67 | 4.31 | 5.15 | 5.49 | 5.75 | 6.60 |
| Total Shareholders' Equity | 3.13M | 16.85M | 13.16M | 18.33M | 24.05M | 9.31M | 7.06M | -1.75M | -3.35M | -7.75M | 6.66M | 20.74M | 20.14M | 28.32M | 29.96M | 35.23M | 42.04M | 44.49M | 46.53M | 48.61M |
| Common Stock | 2.85K | 2.72K | 2.02K | 1.95K | 1.95K | 1.41K | 1.33K | 1.17K | 1.1K | 1.05K | 902 | 902 | 822 | 816 | 816 | 816 | 816 | 810 | 810 | 809 |
| Retained Earnings | -181.31M | -163.7M | -153.87M | -146.61M | -140.39M | -134.85M | -128.98M | -116.35M | -111.33M | -110.26M | -88.05M | -73.33M | -63.79M | -54.05M | -50.96M | -43.34M | -34.62M | -28.73M | -22.81M | -19.96M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |